Page last updated: 2024-08-16

3,3',4,5'-tetrahydroxystilbene and Cancer of Prostate

3,3',4,5'-tetrahydroxystilbene has been researched along with Cancer of Prostate in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhar, S; Dias, SJ; Levenson, AS; Li, K; Mizuno, CS; Penman, AD; Rimando, AM1
Biswas, PK; Butt, NA; Chakraborty, S; Kumar, A; Levenson, AS; Rimando, AM; Williams, R; Zhang, L1
Cho, HJ; Kim, JK; Lee, BY; Lee, YM; Lim, DY; Park, JH; Seon, MR1
Jun, JG; Kim, EJ; Park, H; Park, JH; Park, SY1
Her, S; Jun, JG; Jung, JI; Kim, JK; Kwon, GT; Park, JH; Song, HR; Woo, EY1
Barton, A; Barton, BE; Huang, HF; Karras, JG; Murphy, TF1
Ghidoni, R; Macchia, M; Minutolo, F; Sacchi, N; Sala, G1

Other Studies

7 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Cancer of Prostate

ArticleYear
Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts.
    The Prostate, 2013, Volume: 73, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Growth Inhibitors; Male; Mice; Mice, Nude; Prostatic Neoplasms; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays

2013
Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions.
    Molecular bioSystems, 2016, Volume: 12, Issue:5

    Topics: Androgen Antagonists; Cell Line, Tumor; Computer Simulation; Flutamide; Humans; Hydrogen Bonding; Male; Molecular Conformation; Molecular Dynamics Simulation; Mutant Proteins; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Resveratrol; Stilbenes; Thermodynamics

2016
Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity.
    Cancer letters, 2009, Nov-28, Volume: 285, Issue:2

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinases; Flow Cytometry; Humans; Immunoblotting; Immunoprecipitation; Male; Prostatic Neoplasms; Stilbenes

2009
The grape component piceatannol induces apoptosis in DU145 human prostate cancer cells via the activation of extrinsic and intrinsic pathways.
    Journal of medicinal food, 2009, Volume: 12, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Humans; Intracellular Signaling Peptides and Proteins; Male; Mitochondrial Membranes; Mitochondrial Proteins; Phytotherapy; Plant Extracts; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Signal Transduction; Stilbenes; Vitis

2009
Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling.
    The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:3

    Topics: Animals; Cell Line, Tumor; Epidermal Growth Factor; Gene Expression Regulation; Humans; Interleukin-6; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A

2012
Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:1

    Topics: Animals; Apoptosis; Cell Line, Tumor; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Janus Kinase 2; Janus Kinase 3; Male; Oligonucleotides, Antisense; Prostate; Prostatic Neoplasms; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; STAT3 Transcription Factor; Stilbenes; Trans-Activators; Transfection; Tyrphostins

2004
Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells.
    Drugs under experimental and clinical research, 2003, Volume: 29, Issue:5-6

    Topics: Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Ceramides; Humans; Male; Prostatic Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship; Time Factors

2003